My Most Difficult Choice

  • Share

(3 of 3)

Altorki's bigger fear is that the Vioxx scare will deter researchers from doing enough work on COX-2 to understand its true role in cancer. "If we do these studies and they show no evidence of efficacy, then I'm wrong. I'll get off that train and get on another," he says. "But it's important that we find out."

I'm hoping we find out that he's right. --With reporting by Alice Park/New York

Time.com on Digg

POWERED BY digg